September 24, 2025 When High Hospital Prices Mean Higher Risk High-markup hospitals, often for-profit, were tied to higher surgical risks, with commentary calling for transparency and oversight. Conexiant
September 12, 2025 FDA Considers Ending Routine Advisory Committees on New Drugs The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency. KFF Health News
June 17, 2025 FMT as First-Line CDI Treatment? New randomized trial shows fecal microbiota transplantation may reduce antibiotic dependence in first-episode infections Conexiant
August 18, 2025 Health Groups Respond to 'National Scandal' With elder homelessness rising, PACE programs funded by Medicaid and Medicare secure housing and health care for low-income seniors, seen in Rhode Island. KFF Health News
July 21, 2025 Stanford Physician-Scientist Takes CDER Helm Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs. Conexiant